FrancophonIA/ELRC3.0 huggingface dataset:
English: MicardisPlus is a combination of two active substances, telmisartan and hydrochlorothiazide in one tablet.
Croatian: MicardisPlus je kombinacija dviju djelatnih tvari, telmisartana i hidroklorotiazida, u jednoj tableti.
English: What you need to know before you take MicardisPlus
Croatian: Što morate znati prije nego počnete uzimati MicardisPlus
English: MicardisPlus is not recommended during pregnancy, and must not be taken when more than 3 months pregnant, as it may cause serious harm to your baby if used after the third month of pregnancy.
Croatian: MicardisPlus se ne preporučuje u trudnoći, te se ne smije primjenjivati kada ste trudni dulje od 3 mjeseca, jer može izazvati ozbiljno oštećenje bebe kada se primjenjuje nakon trećeg mjeseca trudnoće.
English: If you forget to take MicardisPlus
Croatian: Ako ste zaboravili uzeti MicardisPlus
English: Therefore, the use of MicardisPlus is not recommended.
Croatian: Stoga se ne preporučuje primjena MicardisPlusa.
English: Hydrochlorothiazide: Following oral administration of MicardisPlus peak concentrations of hydrochlorothiazide are reached in approximately 1.0 - 3.0 hours after dosing.
Croatian: Hidroklorotiazid: Nakon peroralne primjene MicardisPlusa, vršne koncetracije hidroklorotiazida postižu se za oko 1,0-3,0 sati nakon doziranja.
English: If you take more MicardisPlus than you should If you accidentally take too many tablets you may experience symptoms such as low blood pressure and rapid heartbeat.
Croatian: Ako slučajno uzmete previše tableta, može doći do pojave simptoma kao što su niski krvni tlak i ubrzani otkucaji srca.
English: MARKETING AUTHORISATION NUMBER(S) EU/1/02/213/017-023
Croatian: BROJ(EVI) ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET EU/1/02/213/017-023
English: MicardisPlus should be taken in patients whose blood pressure is not adequately controlled by telmisartan alone.
Croatian: MicardisPlus namijenjen je bolesnicima čiji se krvni tlak ne može adekvatno kontrolirati samo telmisartanom.
English: Do not take MicardisPlus
Croatian: Nemojte uzimati MicardisPlus
English: If any of the above applies to you, tell your doctor or pharmacist before taking MicardisPlus.
Croatian: Ako se nešto od gore navedenog odnosi na Vas, obratite se liječniku ili ljekarniku prije nego počnete uzimati MicardisPlus.
English: Increased incidence of sepsis has been observed with telmisartan only, however can not be ruled out for MicardisPlus.
Croatian: Povećana učestalost sepse je zapažena samo uz telmisartan, ali ne može se isključiti za MicardisPlus.
English: Although clinically significant hyperkalaemia has not been documented with MicardisPlus, risk factors for the development of hyperkalaemia include renal insufficiency and/or heart failure, and diabetes mellitus.
Croatian: Iako klinički značajna hiperkalemija nije zabilježena uz MicardisPlus, rizični faktori za razvoj hiperkalemije uključuju renalnu insuficijenciju i/ili zatajenje srca, te dijabetes melitus.
English: Experience with MicardisPlus is modest in the patients with mild to moderate renal impairment, therefore periodic monitoring of potassium, creatinine and uric acid serum levels is recommended.
Croatian: Iskustvo s MicardisPlusom je skromno kod bolesnika s blagim do umjerenim oštećenjem funkcije bubrega, stoga se preporučuje periodično praćenje serumskih vrijednosti kalija, kreatinina i mokraćne kiseline.
English: In case of surgery or anaesthetics, you should tell your doctor that you are taking MicardisPlus.
Croatian: Ako trebate na operaciju ili primati anestetik, morate biti sigurni da Vaš liječnik zna da uzimate MicardisPlus.
English: Possible side effects of MicardisPlus:
Croatian: Moguće nuspojave MicardisPlusa:
English: Rottendorf Pharma GmbH Ostenfelder Straße 51 - 61 D-59320 Ennigerloh
Croatian: Rottendorf Pharma GmbH Ostenfelder Straße 51 - 61 D-59320 Ennigerloh Njemačka
English: MicardisPlus is a combination of an angiotensin II receptor antagonist, telmisartan, and a thiazide diuretic, hydrochlorothiazide.
Croatian: MicardisPlus je kombinacija antagonista receptora angiotenzina II, telmisartana i tiazidskog diuretika, hidroklorotiazida.
English: In addition, MicardisPlus should be used with caution in patients with impaired hepatic function or progressive liver disease, since minor alterations of fluid and electrolyte balance may precipitate hepatic coma.
Croatian: Nadalje, MicardisPlus se mora primjenjivati s oprezom kod bolesnika s oštećenom jetrenom funkcijom ili progresivnom bolesti jetre, s obzirom da manje promjene u ravnoteži tekućine i elektrolita mogu precipitirati hepatičku komu.
English: There is no experience regarding the administration of MicardisPlus in patients with recent kidney transplantation.
Croatian: Ne postoji iskustvo glede primjene MicardisPlusa kod bolesnika s nedavno presađenim bubregom.
English: The use of MicardisPlus during breast feeding is not recommended.
Croatian: Primjena MicardisPlusa tijekom dojenja se ne preporučuje.
English: Adverse reactions of unknown frequency reported with the use of hydrochlorothiazide alone include:
Croatian: Nuspojave nepoznate učestalosti prijavljene uz primjenu samog hidroklorotiazida uključuju:
English: Adverse reactions known to occur with each component given singly but which have not been seen in clinical trials may occur during treatment with MicardisPlus.
Croatian: Nuspojave za koje se zna da se pojavljuju sa svakom komponentom zasebno, ali nisu bile primijećene u kliničkim ispitivanjima mogu se pojaviti tijekom liječenja MicardisPlusom.
English: Precautions to be taken before handling or administering the medicinal product MicardisPlus should be kept in the sealed blister due to the hygroscopic property of the tablets.
Croatian: Mjere opreza koje je potrebno poduzeti prije rukovanja ili primjene lijeka MicardisPlus se mora čuvati u zatvorenom blisteru zbog higroskopnih svojstava tableta.
English: MicardisPlus should not be given to patients with cholestasis, biliary obstructive disorders or severe hepatic insufficiency (see section 4.3) since telmisartan is mostly eliminated with the bile.
Croatian: MicardisPlus ne smije se davati bolesnicima s kolestazom, bilijarnim opstruktivnim poremećajima ili teškom insuficijencijom jetre (vidjeti dio 4.3), s obzirom da se telmisartan uglavnom eliminira putem žuči.
English: MicardisPlus is used to treat high blood pressure (essential hypertension) in adults whose blood pressure is not controlled enough when telmisartan is used alone.
Croatian: MicardisPlus se primjenjuje u liječenju visokog krvnog tlaka (esencijalna hipertenzija) kod odraslih osoba čiji krvni tlak nije dobro kontroliran uz primjenu samog telmisartana.
English: Sepsis* (often called "blood poisoning"), is a severe infection with whole-body inflammatory response, rapid swelling of the skin and mucosa (angioedema), blistering and peeling of the top layer of skin (toxic epidermal necrolysis); these side effects are rare (may affect up to 1 in 1,000 people) or of unknown frequency (toxic epidermal necrolysis) but are extremely serious and patients should stop taking the medicine and see their doctor immediately.
Croatian: Sepsa* (često se naziva “trovanje krvi”) je teška infekcija s upalnom reakcijom cijelog tijela, brzo oticanje kože i sluznice (angioedem), stvaranje mjehura i ljuštenje gornjeg sloja kože (toksična epidermalna nekroliza); ove nuspojave su rijetke (mogu se javiti u do 1 na 1000 osoba) ili su nepoznate učestalosti (toksična epidermalna nekroliza), ali izuzetno ozbiljne, te bolesnici moraju prekinuti s primjenom lijeka i trenutno se javiti liječniku.
English: If you are intolerant to some sugars, consult your doctor before taking MicardisPlus.
Croatian: Ako ne podnosite neke šećere, posavjetujte se s liječnikom prije početka primjene MicardisPlusa.
English: The safety and efficacy of MicardisPlus in children and adolescents aged below 18 have not been established.
Croatian: Sigurnost i djelotvornost MicardisPlusa u djece i adolescenata u dobi do 18 godina nisu ustanovljene.
English: In patients with mild to moderate hepatic impairment the posology should not exceed MicardisPlus 40 mg/12.5 mg once daily.
Croatian: Kod bolesnika s blagim do umjerenim oštećenjem funkcije jetre doza ne smije prelaziti MicardisPlus 40 mg/12,5 mg jedanput dnevno.
English: MicardisPlus must not be used in patients with severe renal impairment (creatinine clearance <30 ml/min) (see section 4.3).
Croatian: MicardisPlus ne smije se primjenjivati kod bolesnika s teškim oštećenjem funkcije bubrega (klirens kreatinina <30 ml/min) (vidjeti dio 4.3).
English: D-55216 Ingelheim am Rhein Germany and
Croatian: D-55216 Ingelheim am Rhein Njemačka
English: Remove your MicardisPlus tablet from the blister only directly prior to intake.
Croatian: Izvadite MicardisPlus tabletu iz blistera neposredno prije primjene.
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS Unit dose blister 7 or 10-count or any non 7 count blister
Croatian: PODACI KOJE MORA NAJMANJE SADRŽAVATI BLISTER ILI STRIP Blister s jediničnim dozama sa 7 ili 10 tableta ili svaki blister koji ne sadrži 7 tableta
English: MicardisPlus is not indicated in patients with severe hepatic impairment.
Croatian: MicardisPlus nije indiciran kod bolesnika s teškim oštećenjem funkcije jetre.
English: 14 tablets 28 tablets 30 x 1 tablets 56 tablets 90 x 1 tablets 98 tablets 28 x 1 tablets
Croatian: 14 tableta 28 tableta 30 x 1 tableta 56 tableta 90 x 1 tableta 98 tableta 28 x 1 tableta
English: MicardisPlus should be kept in the sealed blister due to the hygroscopic property of the tablets.
Croatian: MicardisPlus je potrebno čuvati u zatvorenom blisteru zbog higroskopskih svojstava tableta.
English: • Severe renal impairment (creatinine clearance < 30 ml/min).
Croatian: • Teško oštećenje funkcije bubrega (klirens kreatinina <30 ml/min).
English: 14 tablets 28 tablets 30 x 1 tablets 56 tablets 84 tablets 90 x 1 tablets 98 tablets 28 x 1 tablets
Croatian: 14 tableta 28 tableta 30 x 1 tableta 56 tableta 84 tablete 90 x 1 tableta 98 tableta 28 x 1 tableta
English: Adverse reactions previously reported with one of the individual components may be potential adverse reactions with MicardisPlus, even if not observed in clinical trials with this product.
Croatian: Nuspojave prethodno prijavljene s jednom od individualnih komponenti mogu biti potencijalne nuspojave MicardisPlusa, čak iako nisu zabilježene u kliničkim ispitivanjima ovoga lijeka.
English: The effect of MicardisPlus may be reduced when you take NSAIDs (non steroidal anti-inflammatory medicines, e.g. aspirin or ibuprofen).
Croatian: Učinak MicardisPlusa se može smanjiti dok uzimate NSAIL-ove (nesteroidni protuupalni lijekovi, npr. acetilsalicilatnu kiselinu ili ibuprofen).
English: Adverse reactions reported with one of the individual components may be potential adverse reactions with MicardisPlus, even if not observed in clinical trials with this product.
Croatian: Nuspojave prijavljene uz jednu od pojedinih komponenti mogu biti potencijalne nuspojave uz MicardisPlus, čak ako i nisu primijećene u kliničkim ispitivanjima s ovim lijekom.
English: Some people feel dizzy or tired when taking MicardisPlus.
Croatian: Neke osobe mogu osjećati omaglicu ili umor tijekom primjene MicardisPlusa.
English: The concomitant use of MicardisPlus with aliskiren-containing products is contraindicated in patients with diabetes mellitus or renal impairment (GFR < 60 ml/min/1.73 m2) (see sections 4.5 and 5.1).
Croatian: Istodobna primjena MicardisPlusa s lijekovima koji sadrže aliskiren kontraindicirana je u bolesnika sa šećernom bolešću ili oštećenjem funkcije bubrega (GFR < 60 ml/min/1,73 m2) (vidjeti dijelove 4.5 i
English: There is no clinical experience with MicardisPlus in patients with hepatic impairment.
Croatian: Nema kliničkog iskustva s MicardisPlusom kod bolesnika s oštećenjem funkcije jetre.
English: Infections and infestations Not known:
Croatian: Infekcije i infestacije Nepoznato:
English: How to take MicardisPlus
Croatian: Kako uzimati MicardisPlus
English: MicardisPlus fixed dose combination (40 mg telmisartan/12.5 mg hydrochlorothiazide and 80 mg telmisartan/12.5 mg hydrochlorothiazide) is indicated in adults whose blood pressure is not adequately controlled on telmisartan alone.
Croatian: MicardisPlus je kombinacija fiksne doze (40 mg telmisartana/12,5 mg hidroklorotiazida i 80 mg telmisartana/12,5 mg hidroklorotiazida), indicirana kod odraslih bolesnika čiji se krvni tlak ne može adekvatno kontrolirati samo telmisartanom.
English: • MicardisPlus 40 mg/12.5 mg may be administered once daily in patients whose blood pressure is not adequately controlled by Micardis 40 mg
Croatian: • MicardisPlus 40 mg/12,5 mg se primjenjuje jedanput dnevno kod bolesnika čiji se krvni tlak adekvatno ne kontrolira Micardisom 40 mg
English: Skin and subcutaneous tissue disorders Not known:
Croatian: Poremećaji kože i potkožnog tkiva Nepoznato:
English: Dizziness or drowsiness may occasionally occur when taking MicardisPlus.
Croatian: Kod uzimanja MicardisPlusa mogu se povremeno pojaviti omaglica ili omamljenost.
English: Other medicines used to treat high blood pressure, corticosteroids, painkillers (such as nonsteroidal anti-inflammatory drugs [NSAIDs], medicines to treat cancer, gout, or arthritis.
Croatian: - Drugi lijekovi koji se primjenjuju u liječenju visokog krvnog tlaka, kortikosteroidi, lijekovi protiv bolova (kao što su nesteroidni protuupalni lijekovi [NSAIL-ovi]), lijekovi za liječenje raka, gihta, ili artritisa.
English: • MicardisPlus 80 mg/12.5 mg may be administered once daily in patients whose blood pressure is not adequately controlled by Micardis 80 mg
Croatian: • MicardisPlus 80 mg/12,5 mg se primjenjuje jedanput dnevno kod bolesnika čiji se krvni tlak adekvatno ne kontrolira Micardisom 80 mg
English: Children and adolescents The use of MicardisPlus in children and adolescents up to the age of 18 years is not recommended.
Croatian: Djeca i adolescenti Primjena MicardisPlusa kod djece i adolescenata ispod 18 godina starosti se ne preporučuje.
English: Blood and lymphatic system disorders Rare:
Croatian: Poremećaji krvi i limfnog sustava Rijetko:
English: Aanaemia Eosinophilia, thrombocytopenia
Croatian: Eozinofilija, trombocitopenija
English: The use of MicardisPlus in children and adolescents up to the age of 18 years is not recommended.
Croatian: Primjena MicardisPlusa kod djece i adolescenata ispod 18 godina starosti se ne preporučuje.
English: MicardisPlus 40 mg/12.5 mg tablets EU/1/02/213/001-005, 011, 013-014
Croatian: EU/1/02/213/001-005, 011, 013-014
English: MicardisPlus 80 mg/25 mg may be administered once daily in patients whose blood pressure is not adequately controlled by MicardisPlus 80 mg/12.5 mg or in patients who have been previously stabilised on telmisartan and hydrochlorothiazide given separately.
Croatian: MicardisPlus 80 mg/25 mg se primjenjuje jedanput dnevno kod bolesnika čiji se krvni tlak adekvatno ne kontrolira s MicardisPlus 80 mg/12,5 mg ili bolesnika koji su prethodno stabilizirani zasebnim terapijama telmisartana i hidroklorotiazida.
English: - Hyponatraemia and hypochloraemic alkalosis There is no evidence that MicardisPlus would reduce or prevent diuretic-induced hyponatraemia.
Croatian: Ne postoje dokazi da MicardisPlus smanjuje ili sprječava hiponatremiju induciranu diureticima.
English: EU/1/02/213/017 14 tablets EU/1/02/213/018 28 tablets EU/1/02/213/019 28 x 1 tablets EU/1/02/213/020 30 x 1 tablets EU/1/02/213/021 56 tablets EU/1/02/213/022 90 x 1tablets EU/1/02/213/023 98 tablets
Croatian: EU/1/02/213/017 14 tableta EU/1/02/213/018 28 tableta EU/1/02/213/019 28 x 1 tableta EU/1/02/213/020 30 x 1 tableta EU/1/02/213/021 56 tableta EU/1/02/213/022 90 x 1tableta EU/1/02/213/023 98 tableta
English: MicardisPlus is also available at the dose strengths 40 mg/12.5 mg and 80 mg/ 12.5 mg Renal impairment
Croatian: MicardisPlus je također dostupan u jačinama 40 mg/12,5 mg i 80 mg/ 12,5 mg.
English: How to store MicardisPlus
Croatian: Kako čuvati MicardisPlus
English: NAME OF THE MEDICINAL PRODUCT MicardisPlus 80 mg/25 mg tablets
Croatian: NAZIV LIJEKA MicardisPlus 80 mg/25 mg tablete
English: INFORMATION IN BRAILLE MicardisPlus 80 mg/25 mg
Croatian: 16. PODACI NA BRAILLEOVOM PISMU MicardisPlus 80 mg/25 mg
English: EU/1/02/213/001 14 tablets EU/1/02/213/002 28 tablets EU/1/02/213/003 28 x 1 tablets EU/1/02/213/013 30 x 1 tablets EU/1/02/213/004 56 tablets EU/1/02/213/011 84 tablets EU/1/02/213/014 90 x 1 tablets EU/1/02/213/005 98 tablets
Croatian: EU/1/02/213/001 14 tableta EU/1/02/213/002 28 tableta EU/1/02/213/003 28 x 1 tableta EU/1/02/213/013 30 x 1 tableta EU/1/02/213/004 56 tableta EU/1/02/213/011 84 tableta EU/1/02/213/014 90 x 1 tableta EU/1/02/213/005 98 tableta
English: MicardisPlus 80 mg/12.5 mg tablets EU/1/02/213/006-010, 012, 015-016
Croatian: EU/1/02/213/006-010, 012, 015-016
English: EU/1/02/213/006 14 tablets EU/1/02/213/007 28 tablets EU/1/02/213/008 28 x 1 tablets EU/1/02/213/015 30 x 1 tablets EU/1/02/213/009 56 tablets EU/1/02/213/012 84 tablets EU/1/02/213/016 90 x 1 tablets EU/1/02/213/010 98 tablets
Croatian: EU/1/02/213/006 14 tableta EU/1/02/213/007 28 tableta EU/1/02/213/008 28 x 1 tableta EU/1/02/213/015 30 x 1 tableta EU/1/02/213/009 56 tableta EU/1/02/213/012 84 tableta EU/1/02/213/016 90 x 1 tableta EU/1/02/213/010 98 tableta
English: Blood uric acid increased Blood creatinine increased, blood creatine phosphokinase increased, hepatic enzyme increased
Croatian: Povišene vrijednosti kreatinina u krvi, povišene vrijednosti kreatin fosfokinaze, povišene vrijednosti jetrenih enzima na osnovi iskustva u razdoblju nakon stavljanja lijeka u promet
English: MicardisPlus fixed dose combination (80 mg telmisartan/25 mg hydrochlorothiazide) is indicated in adults whose blood pressure is not adequately controlled on MicardisPlus 80 mg/12.5 mg (80 mg telmisartan/12.5 mg hydrochlorothiazide) or adults who have been previously stabilised on telmisartan and hydrochlorothiazide given separately.
Croatian: MicardisPlus je kombinacija fiksne doze (80 mg telmisartana/25 mg hidroklorotiazida), indicirana kod odraslih osoba čiji se krvni tlak ne može adekvatno kontrolirati s MicardisPlus 80 mg/12,5 mg (80 mg telmisartana / 12,5 mg hidroklorotiazida) ili odraslih osoba koje su prethodno stabilizirane zasebnim terapijama telmisartana i hidroklorotiazida.
English: Jaundice hepatocellular, jaundice cholestatic
Croatian: Hepatocelularna žutica, kolestatska žutica
English: MicardisPlus 80 mg/12.5 mg tablets
Croatian: MicardisPlus 80 mg/12,5 mg tablete
English: Potassium-sparing diuretics, potassium supplements or potassium-containing salt substitutes should be co-administered cautiously with MicardisPlus (see section 4.5).
Croatian: Ako se uz MicardisPlus istodobno primjenjuju diuretici koji štede kalij, nadomjesci kalija, ili zamjene za sol koje sadrže kalij potreban je oprez (vidjeti dio 4.5).
English: INFORMATION IN BRAILLE MicardisPlus 40 mg/12.5 mg
Croatian: 16. PODACI NA BRAILLEOVOM PISMU MicardisPlus 40 mg/12,5 mg
English: Yellow and white oval shaped tablet of 6.2 mm engraved with the company logo and the code 'H9'.
Croatian: Žuto-bijele ovalne tablete duljine 6,2 mm, s utisnutim logom tvrtke i kodom 'H9'.
English: MicardisPlus 80 mg/12.5 mg tablets Each tablet contains 80 mg telmisartan and 12.5 mg hydrochlorothiazide.
Croatian: MicardisPlus 80 mg/12,5 mg tablete Jedna tableta sadržava 80 mg telmisartana i 12,5 mg hidroklorotiazida.
English: MicardisPlus 40 mg/12.5 mg tablets Each tablet contains 40 mg telmisartan and 12.5 mg hydrochlorothiazide.
Croatian: MicardisPlus 40 mg/12,5 mg tablete Jedna tableta sadržava 40 mg telmisartana i 12,5 mg hidroklorotiazida.
English: MicardisPlus 80 mg/25 mg tablets are yellow and white, oval-shaped, two-layer tablets engraved with the company logo and the code 'H9'.
Croatian: MicardisPlus 80 mg/25 mg tablete su žuto-bijele dvoslojne tablete ovalnog oblika, s urezanim logom tvrtke i oznakom „H9“.
English: INFORMATION IN BRAILLE MicardisPlus 80 mg/12.5 mg
Croatian: 16. PODACI NA BRAILLEOVOM PISMU MicardisPlus 80 mg/12,5 mg
English: MicardisPlus 40 mg/12.5 mg tablets are red and white, oval-shaped two-layer tablets engraved with the company logo and the code 'H4'.
Croatian: MicardisPlus 40 mg/12,5 mg tablete su crveno-bijele dvoslojne tablete ovalnog oblika, s urezanim logom tvrtke i oznakom „H4“.
English: MicardisPlus 80 mg/12.5 mg tablets are red and white, oval-shaped, two-layer tablets engraved with the company logo and the code 'H8'.
Croatian: MicardisPlus 80 mg/12,5 mg tablete su crveno-bijele dvoslojne tablete ovalnog oblika, s urezanim logom tvrtke i oznakom „H8“.
English: NAME OF THE MEDICINAL PRODUCT MicardisPlus 80 mg/25 mg tablets telmisartan/hydrochlorothiazide
Croatian: NAZIV LIJEKA MicardisPlus 80 mg/25 mg tablete telmisartan/hidroklorotiazid
English: Periodic monitoring of serum potassium and ECG is recommended when MicardisPlus is administered with medicinal products affected by serum potassium disturbances (e.g. digitalis glycosides, antiarrhythmics) and the following torsades de pointes inducing medicinal products (which include some antiarrhythmics), hypokalaemia being a predisposing factor to torsades de pointes.
Croatian: Preporučuje se periodično praćenje kalija u serumu i EKG kada se MicardisPlus uzima s lijekovima na koje utječu poremećaji kalija u serumu (npr. glikozidi digitalisa, antiaritmici) i sljedećim lijekovima koji induciraju torsades de pointes (što uključuje pojedine antiaritmike), s hipokalemijom kao predisponirajućim faktorom za torsades de pointes. - skupina Ia antiaritmika (npr. kinidin, hidrokinidin, dizopiramid) - skupina III antiaritmika (npr. amiodaron, sotalol, dofetilid, ibutilid) - neki antipsihotici (npr. tioridazin, klorpromazin, levomepromazin, trifluoperazin, cijamemazin,
English: MicardisPlus is available in blisters packs containing 14, 28, 56, 84, or 98 tablets, or unit dose blister packs containing 28 x 1, 30 x 1 or 90 x 1 tablets.
Croatian: MicardisPlus je dostupan u blister pakiranjima koja sadrže 14, 28, 56, 84, ili 98 tableta, ili u blisterima s jediničnim dozama s 28 x 1, 30 x 1, ili 90 x 1 tableta.
English: MicardisPlus is available in blister packs containing 14, 28, 56, or 98 tablets, or unit dose blister packs containing 28 x 1, 30 x 1 or 90 x 1 tablets
Croatian: MicardisPlus je dostupan u blister pakiranjima koja sadrže 14, 28, 56, ili 98 tableta, ili u blisterima s jediničnim dozama s 28 x 1, 30 x 1, ili 90 x 1 tableta.
English: MicardisPlus 80 mg/25 mg tablets telmisartan/hydrochlorothiazide
Croatian: MicardisPlus 80 mg/25 mg tablete telmisartan/hidroklorotiazid
English: Pack sizes: - Blister with 14, 28, 56, 84, or 98 tablets or - Perforated unit dose blisters with 28 x 1, 30 x 1 or 90 x 1 tablets.
Croatian: Veličine pakiranja: - Blister s 14, 28, 56, 84, ili 98 tableta ili - Perforirani blisteri s jediničnim dozama s 28 x 1, 30 x 1 ili 90 x 1 tableta.
English: The overall incidence and pattern of adverse reactions reported with MicardisPlus 80 mg/25 mg was comparable with MicardisPlus 80 mg/12.5 mg. A dose-relationship of adverse reactions was not established and they showed no correlation with gender, age or race of the patients.
Croatian: Ukupna incidencija i obrazac nuspojava prijavljenih uz MicardisPlus 80 mg/25 mg usporedivi su s MicardisPlus 80 mg/12,5 mg.
English: Pack sizes: - Blister with 14, 28, 56, or 98 tablets or - Perforated unit dose blisters with 28 x 1, 30 x 1 or 90 x 1 tablets.
Croatian: Veličine pakiranja: - Blister s 14, 28, 56, ili 98 tableta ili - Perforirani blisteri s jediničnim dozama s 28 x 1, 30 x 1, ili 90 x 1 tableta.